Insider Selling: HealthEquity, Inc. (NASDAQ:HQY) Director Sells $630,962.45 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the transaction, the director now owns 6,070 shares of the company’s stock, valued at $497,072.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

HealthEquity Price Performance

NASDAQ:HQY opened at $75.73 on Friday. The business’s 50-day moving average price is $81.46 and its 200 day moving average price is $79.09. The firm has a market cap of $6.59 billion, a P/E ratio of 82.32, a PEG ratio of 1.37 and a beta of 0.57. HealthEquity, Inc. has a 52-week low of $61.32 and a 52-week high of $88.26. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. The business had revenue of $287.60 million during the quarter, compared to analyst estimates of $278.78 million. As a group, sell-side analysts predict that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently made changes to their positions in the company. Lindbrook Capital LLC raised its stake in shares of HealthEquity by 22.7% in the 1st quarter. Lindbrook Capital LLC now owns 698 shares of the company’s stock valued at $57,000 after acquiring an additional 129 shares in the last quarter. Xponance Inc. raised its stake in shares of HealthEquity by 1.2% in the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock valued at $813,000 after acquiring an additional 147 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of HealthEquity by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock valued at $426,000 after acquiring an additional 197 shares in the last quarter. KLR Investment Advisors LLC raised its stake in shares of HealthEquity by 4.2% in the 4th quarter. KLR Investment Advisors LLC now owns 5,914 shares of the company’s stock valued at $392,000 after acquiring an additional 241 shares in the last quarter. Finally, Capstone Investment Advisors LLC raised its stake in shares of HealthEquity by 7.0% in the 4th quarter. Capstone Investment Advisors LLC now owns 3,710 shares of the company’s stock valued at $246,000 after acquiring an additional 243 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upped their target price on shares of HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. Robert W. Baird increased their target price on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. Raymond James increased their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. JMP Securities increased their price target on shares of HealthEquity from $101.00 to $105.00 and gave the stock a “market outperform” rating in a research report on Tuesday, June 4th. Finally, Bank of America reaffirmed a “buy” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, July 3rd. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.67.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.